Teva (TEVA) Pharmaceutical and Shanghai Fosun Pharmaceutical announced that the companies, through their respective subsidiaries, have entered a strategic partnership for the development of ...

Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanomaFosun Pharma-Teva collaboration agreement established ...

Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic Design.

Teva’s plan (PDF) to reach $5 billion in 2030 innovative drug sales places the greatest emphasis on Austedo, which the company foresees hitting at least $2.5 billion in 2027 before reaching a ...

Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with ...

Teva retains all development, manufacturing and commercialization rights to the licensed molecule in the rest of the world. The strategic partnership presents a significant step forward in the global ...

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and ...

Teva Pharmaceutical. Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in ...

There's an unofficial Teva sale happening this weekend. Save up to 40% on sandals for hiking, water activities and camping.